The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment

M Wang, Y Zhang, C Li, W Chang, L Zhang - Frontiers in Immunology, 2023 - frontiersin.org
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has posed a global health crisis. Increasing …

Profiles of gut microbiota associated with clinical outcomes in patients with different stages of SARS-CoV-2 infection

K Krasaewes, R Chaiwarith, N Chattipakorn… - Life Sciences, 2023 - Elsevier
The correlation between SARS-CoV-2 infection and gut microbiota has been a subject of
growing interest in recent research endeavors. It is postulated that SARS-CoV-2 might lead …

Baseline gut microbiome signatures correlate with immunogenicity of SARS-CoV-2 mRNA vaccines

L Daddi, Y Dorsett, T Geng, S Bokoliya, H Yuan… - International Journal of …, 2023 - mdpi.com
The powerful immune responses elicited by the mRNA vaccines targeting the SARS-CoV-2
Spike protein contribute to their high efficacy. Yet, their efficacy can vary greatly between …

Saliva microbiome in relation to SARS-CoV-2 infection in a prospective cohort of healthy US adults

AJS Armstrong, DB Horton, T Andrews, P Greenberg… - …, 2023 - thelancet.com
Background The clinical outcomes of SARS-CoV-2 infection vary in severity, potentially
influenced by the resident human microbiota. There is limited consensus on conserved …

Metformin therapy changes gut microbiota alpha-diversity in COVID-19 patients with type 2 diabetes: the role of SARS-CoV-2 variants and antibiotic treatment

P Petakh, I Kamyshna, V Oksenych, D Kainov… - Pharmaceuticals, 2023 - mdpi.com
The gut microbiota play a crucial role in maintaining host health and have a significant
impact on human health and disease. In this study, we investigated the alpha diversity of gut …

High incidence of candidemia in critically ill COVID-19 patients supported by veno-venous extracorporeal membrane oxygenation: a retrospective study

F Alessandri, G Ceccarelli, G Migliara, V Baccolini… - Journal of Fungi, 2023 - mdpi.com
Background: The incidence of candidemia in severe COVID-19 patients (0.8–14%) is two-to
ten-fold higher than in non-COVID-19 patients. Methods: This retrospective analysis aimed …

[HTML][HTML] Mechanisms of gastrointestinal barrier dysfunction in COVID-19 patients

W Xue, M Honda, T Hibi - World Journal of Gastroenterology, 2023 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) caused by the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a major global public health …

Explore the changes of intestinal flora in patients with coronavirus disease 2019 based on bioinformatics

G Huang, Y Mao, W Zhang, Q Luo, R Xie… - Frontiers in Cellular …, 2023 - frontiersin.org
Background Studies have revealed that there were significant changes in intestinal flora
composition in patients with coronavirus disease 2019 (COVID-19) compared to non-COVID …

Immune Mechanisms Underpinning Long COVID: Collegium Internationale Allergologicum Update 2024

EUC Venterb, PSJ Rohrhofera… - Int Arch Allergy …, 2024 - karger.com
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can
result in a prolonged multisystem disorder termed long COVID, which may affect up to 10 …

[HTML][HTML] Intestinal dysbiosis in pediatric Crohn's disease patients with IL10RA mutations

AJ Xue, SJ Miao, H Sun, XX Qiu, SN Wang… - World journal of …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Several studies have employed animal models to explore the association
between microbiota and interleukin (IL) 10 signaling; however, limited information is …